FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024091106> ?p ?o ?g. }

• W2024091106 endingPage "564" @default.
• W2024091106 startingPage "560" @default.
• W2024091106 abstract "HepatologyVolume 4, Issue 3 p. 560-564 EditorialsFree Access Propranolol in Portal Hypertension: Problems in Paradise? Harold O. Conn, Corresponding Author Harold O. Conn Harold O. Conn, M.D., Veterans Administration Medical Center, West Spring Street, West Haven, Connecticut 06516.Veterans Administration Medical Center West Haven, Connecticut 06516 and The Yale University School of Medicine New Haven, Connecticut 06510===Search for more papers by this author Harold O. Conn, Corresponding Author Harold O. Conn Harold O. Conn, M.D., Veterans Administration Medical Center, West Spring Street, West Haven, Connecticut 06516.Veterans Administration Medical Center West Haven, Connecticut 06516 and The Yale University School of Medicine New Haven, Connecticut 06510===Search for more papers by this author First published: May‐June 1984 https://doi.org/10.1002/hep.1840040333Citations: 22AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Lebrec D, Nouel O, Corbie M, et al. Propranolol–A medical treatment for portal hypertension? Lancet 1980; 2: 180– 182. 2 Lebrec D, Nouel O, Bernuau J, et al. Propranolol in prevention of recurrent gastrointestinal bleeding in cirrhotic patients. Lancet 1981; 1: 920– 921. 3 Lebrec D, Poynard T, Hillon P, et al. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. A controlled study. N Engl J Med 1981; 305: 1371– 1374. 4 Lebrec D, Poynard T, Bercoff E, et al. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology 1984; 4: 355– 358. 5 Conn HO. Propranolol in the treatment of portal hypertension: a caution. Hepatology 1982; 2: 641– 644. 6 Burroughs AK, Jenkins WJ, Sherlock S, et al. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med 1983; 309: 1539– 1542. 7 Resnick RH, Iber FL, Ishihara AM. A controlled study of the therapeutic portacaval shunt. Gastroenterology 1974; 67: 843– 857. 8 Jackson FC, Perrin EB, Felix R, et al. A clinical investigation of the portacaval shunt: V. Survival analysis of the therapeutic operation. Ann Surg 1971; 174: 672– 701. 9 Rueff B, Degos F, Degos JD, et al. A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis. Lancet 1976; 1: 655– 659. 10 Reynolds TB, Donovan AJ, Mikkelsen WP, et al. Results of a 12 year randomized trial of portacaval shunt in patients with alcoholic liver disease and bleeding varices. Gastroenterology 1981; 80: 1005– 1011. 11 Rikkers LF, Rudman D, Galambos JT, et al. A randomized, controlled trial of the distal splenorenal shunt. Ann Surg 1978; 188: 271– 282. 12 Conn HO, Resnick RH, Grace ND, et al. Distal splenorenal shunt vs. portal-systemic shunt: current status of a controlled trial. Hepatology 1981; 1: 151– 160. 13 Langer B, Taylor BR, Mackenzie DR, et al. Further report of a prospective randomized trial comparing distal splenorenal shunt to end-to-side portacaval shunt: an analysis of encephalopathy, survival, and quality of life. Gastroenterology 1984 (in press). 14 Conn HO. A peek at the Child-Turcotte classification. Hepatology 1981; 1: 673– 676. 15 Brantigan CO, Brantigan TA, Joseph N. Effect of beta blockade and beta stimulation on stage fright. Am J Med 1982; 72: 88– 94. 16 Copenhagen Study Group for Liver Diseases. Sexascites, and alcoholism in survival of patients with cirrhosis: effect of prednisone. N Engl J Med 1974; 291: 271– 273. 17 Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1– 39. 18 VanBuuren HR, Koorevaar G, van der Velden PC. Propranolol increases arterial ammonia in liver cirrhosis. Lancet 1982; 2: 951– 952. 19 Conn HO. Trailmaking and NCT in the assessment of mental state in portal-systemic encephalopathy. Dig Dis 1977; 22: 541– 550. 20 Tarver D, Walt RP, Dunk AA, et al. Precipitation of hepatic encephalopathy by propranolol in cirrhosis. Br Med J 1983; 287: 585. 21 Hillon P, Lebrec D, Munoz C, et al. Comparison of the effects of a cardioselective and a nonselective /i-blockade on portal hypertension in patients with cirrhosis. Hepatology 1982; 2: 528– 531. 22 Butzow GH, Remmecke J, Brauer A. Metoprolol in portal hypertension. A controlled study. Klin Wochenschr 1982; 60: 1311– 1314. 23 Lebrec D, Hillon P, Munoz C, et al. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology 1982; 2: 523– 527. 24 Lebrec D, DeFleury P, Rueff B, et al. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980; 79: 1139– 1144. 25 Conn HO. The varix-volcano connection. Gastroenterology 1980; 79: 1333– 1337. 26 Mitchell KJ, Macdougall BRD, Silk DBA, et al. A prospective reappraisal of emergency endoscopy in patients with portal hypertension. Scand J Gastroenterol 1982; 17: 965– 968. 27 Smith JL, Graham DY. Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology 1982; 82: 968– 973. Citing Literature Volume4, Issue3May‐June 1984Pages 560-564 ReferencesRelatedInformation" @default.
• W2024091106 created "2016-06-24" @default.
• W2024091106 creator A5032347666 @default.
• W2024091106 date "1984-05-01" @default.
• W2024091106 modified "2023-10-16" @default.
• W2024091106 title "Propranolol in Portal Hypertension: Problems in Paradise?" @default.
• W2024091106 cites W1565471557 @default.
• W2024091106 cites W1677778680 @default.
• W2024091106 cites W1972504268 @default.
• W2024091106 cites W1991391866 @default.
• W2024091106 cites W2007612534 @default.
• W2024091106 cites W2018234166 @default.
• W2024091106 cites W2024867919 @default.
• W2024091106 cites W2035563144 @default.
• W2024091106 cites W2038252730 @default.
• W2024091106 cites W2053619102 @default.
• W2024091106 cites W2054125032 @default.
• W2024091106 cites W2056346176 @default.
• W2024091106 cites W2064335749 @default.
• W2024091106 cites W2067864626 @default.
• W2024091106 cites W2071642593 @default.
• W2024091106 cites W2082456963 @default.
• W2024091106 cites W2128257517 @default.
• W2024091106 cites W2141156268 @default.
• W2024091106 cites W2204519992 @default.
• W2024091106 cites W2334200094 @default.
• W2024091106 cites W2340972084 @default.
• W2024091106 cites W2917402386 @default.
• W2024091106 cites W4234102145 @default.
• W2024091106 cites W4254400478 @default.
• W2024091106 cites W4293418190 @default.
• W2024091106 doi "https://doi.org/10.1002/hep.1840040333" @default.
• W2024091106 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6609871" @default.
• W2024091106 hasPublicationYear "1984" @default.
• W2024091106 type Work @default.
• W2024091106 sameAs 2024091106 @default.
• W2024091106 citedByCount "28" @default.
• W2024091106 crossrefType "journal-article" @default.
• W2024091106 hasAuthorship W2024091106A5032347666 @default.
• W2024091106 hasBestOaLocation W20240911061 @default.
• W2024091106 hasConcept C114614502 @default.
• W2024091106 hasConcept C126322002 @default.
• W2024091106 hasConcept C161191863 @default.
• W2024091106 hasConcept C17744445 @default.
• W2024091106 hasConcept C199539241 @default.
• W2024091106 hasConcept C2778151854 @default.
• W2024091106 hasConcept C2778217808 @default.
• W2024091106 hasConcept C2780765947 @default.
• W2024091106 hasConcept C33923547 @default.
• W2024091106 hasConcept C41008148 @default.
• W2024091106 hasConcept C71924100 @default.
• W2024091106 hasConceptScore W2024091106C114614502 @default.
• W2024091106 hasConceptScore W2024091106C126322002 @default.
• W2024091106 hasConceptScore W2024091106C161191863 @default.
• W2024091106 hasConceptScore W2024091106C17744445 @default.
• W2024091106 hasConceptScore W2024091106C199539241 @default.
• W2024091106 hasConceptScore W2024091106C2778151854 @default.
• W2024091106 hasConceptScore W2024091106C2778217808 @default.
• W2024091106 hasConceptScore W2024091106C2780765947 @default.
• W2024091106 hasConceptScore W2024091106C33923547 @default.
• W2024091106 hasConceptScore W2024091106C41008148 @default.
• W2024091106 hasConceptScore W2024091106C71924100 @default.
• W2024091106 hasIssue "3" @default.
• W2024091106 hasLocation W20240911061 @default.
• W2024091106 hasLocation W20240911062 @default.
• W2024091106 hasOpenAccess W2024091106 @default.
• W2024091106 hasPrimaryLocation W20240911061 @default.
• W2024091106 hasRelatedWork W1987105950 @default.
• W2024091106 hasRelatedWork W1989032998 @default.
• W2024091106 hasRelatedWork W2022948112 @default.
• W2024091106 hasRelatedWork W2074171729 @default.
• W2024091106 hasRelatedWork W2267959400 @default.
• W2024091106 hasRelatedWork W2401218416 @default.
• W2024091106 hasRelatedWork W2417955275 @default.
• W2024091106 hasRelatedWork W3030044343 @default.
• W2024091106 hasRelatedWork W361201871 @default.
• W2024091106 hasRelatedWork W4247680379 @default.
• W2024091106 hasVolume "4" @default.
• W2024091106 isParatext "false" @default.
• W2024091106 isRetracted "false" @default.
• W2024091106 magId "2024091106" @default.
• W2024091106 workType "article" @default.